REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC Amendment
31/03/2021 15:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210331:nBw33zsdwa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC Amendment
Ap19
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 29 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,729,032 1.34% 190,557 0.15%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,838,067 1.42% 203,723 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 231.9000 USD
Purchase 7 229.2300 USD
Purchase 10 233.9000 USD
Purchase 100 231.0100 USD
Purchase 100 234.9800 USD
Purchase 101 235.1402 USD
Purchase 112 233.5256 USD
Purchase 140 234.4160 USD
Purchase 200 233.6650 USD
Purchase 200 228.5300 USD
Purchase 220 231.1009 USD
Purchase 300 234.7699 USD
Purchase 400 233.8262 USD
Purchase 412 233.7995 USD
Purchase 500 233.1160 USD
Purchase 601 232.9468 USD
Purchase 635 232.9192 USD
Purchase 840 233.5630 USD
Purchase 848 234.5502 USD
Purchase 893 231.6444 USD
Purchase 900 234.0522 USD
Purchase 927 234.5981 USD
Purchase 976 234.6483 USD
Purchase 1,172 234.3778 USD
Purchase 1,362 233.9733 USD
Purchase 1,569 233.2362 USD
Purchase 2,006 234.5297 USD
Purchase 2,046 233.7466 USD
Purchase 2,488 233.3352 USD
Purchase 2,745 232.1078 USD
Purchase 3,160 230.1590 USD
Purchase 4,805 233.3208 USD
Purchase 5,575 233.5422 USD
Purchase 6,751 232.6093 USD
Purchase 7,055 234.5383 USD
Purchase 9,796 234.4936 USD
Purchase 12,223 232.0760 USD
Purchase 13,114 233.7045 USD
Purchase 22,119 233.9087 USD
Purchase 24,368 230.8799 USD
Purchase 28,112 233.9132 USD
Purchase 29,180 234.6000 USD
Sale 5 232.6870 USD
Sale 6 230.2900 USD
Sale 10 233.9000 USD
Sale 17 232.5905 USD
Sale 26 232.1353 USD
Sale 33 232.5663 USD
Sale 35 232.4968 USD
Sale 35 231.2621 USD
Sale 42 229.2300 USD
Sale 43 232.2079 USD
Sale 45 231.8564 USD
Sale 51 232.1955 USD
Sale 52 231.7772 USD
Sale 100 227.3015 USD
Sale 140 234.4160 USD
Sale 155 231.4217 USD
Sale 200 234.1000 USD
Sale 400 232.2175 USD
Sale 449 234.7625 USD
Sale 472 232.9299 USD
Sale 478 234.6573 USD
Sale 500 234.7995 USD
Sale 500 234.9320 USD
Sale 524 234.6673 USD
Sale 563 233.6999 USD
Sale 673 233.8246 USD
Sale 799 232.8010 USD
Sale 804 233.7806 USD
Sale 1,402 228.4826 USD
Sale 1,512 233.7302 USD
Sale 1,817 233.2834 USD
Sale 2,078 231.4307 USD
Sale 2,128 233.7343 USD
Sale 2,616 231.8596 USD
Sale 3,506 233.5534 USD
Sale 5,331 233.0838 USD
Sale 7,013 234.5701 USD
Sale 7,659 233.0929 USD
Sale 12,920 234.4885 USD
Sale 21,609 233.7136 USD
Sale 28,982 234.6000 USD
Sale 83,188 232.7358 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 31 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210331005659/en/
(https://www.businesswire.com/news/home/20210331005659/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Alphawave IP Group - Form 8.3 ALPHAWAVE IP GROUP PLC
AnnouncementREG - Barclays PLC Alpha Group Intl PLC - Form 8.3 ALPHA GROUP INTERNATIONAL PLC
AnnouncementREG - Barclays PLC Spirent Comms. PLC - Form 8.3 SPIRENT COMMUNICATIONS PLC
AnnouncementREG - Barclays PLC Renewi PLC - Form 8.3 RENEWI PLC
AnnouncementREG - Barclays PLC FD Technologies PLC - Form 8.3 FD TECHNOLOGIES PLC
Announcement